This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 May;13(5):202, 205.

Impact of HAART on HIV-linked malignancies

Jeffrey Laurence

PMID: 12800820

Review

Impact of HAART on HIV-linked malignancies

Jeffrey Laurence. AIDS Read. 2003 May.

. 2003 May;13(5):202, 205.

Author

Jeffrey Laurence

PMID: 12800820

No abstract available

PubMed Disclaimer

Similar articles

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort. Clifford GM, et al. J Natl Cancer Inst. 2005 Mar 16;97(6):425-32. doi: 10.1093/jnci/dji072. J Natl Cancer Inst. 2005. PMID: 15770006
[Epidemiology of HIV-associated malignancies].
Launay O, Guillevin L. Launay O, et al. Bull Cancer. 2003 May;90(5):387-92. Bull Cancer. 2003. PMID: 12850760 Review. French.
Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ. Engels EA, et al. Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487. Int J Cancer. 2008. PMID: 18435450
[HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J, Bossi P. Gabarre J, et al. Bull Cancer. 2003 May;90(5):419-25. Bull Cancer. 2003. PMID: 12850765 Review. French.
The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S, Gill MJ. Gingues S, et al. HIV Med. 2006 Sep;7(6):369-77. doi: 10.1111/j.1468-1293.2006.00395.x. HIV Med. 2006. PMID: 16903981

See all similar articles

Cited by

Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only.
Teng YKO, Schippers EF, Wijermans PW. Teng YKO, et al. Int J Hematol. 2011 Jun;93(6):811-814. doi: 10.1007/s12185-011-0859-y. Epub 2011 May 11. Int J Hematol. 2011. PMID: 21557043 Review.
Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.
Kumar S, Bryant CS, Chamala S, Qazi A, Seward S, Pal J, Steffes CP, Weaver DW, Morris R, Malone JM, Shammas MA, Prasad M, Batchu RB. Kumar S, et al. Mol Cancer. 2009 Apr 22;8:26. doi: 10.1186/1476-4598-8-26. Mol Cancer. 2009. PMID: 19386116 Free PMC article.
An Epigenetic LINE-1-Based Mechanism in Cancer.
Lavia P, Sciamanna I, Spadafora C. Lavia P, et al. Int J Mol Sci. 2022 Nov 23;23(23):14610. doi: 10.3390/ijms232314610. Int J Mol Sci. 2022. PMID: 36498938 Free PMC article. Review.
Drug repositioning for gynecologic tumors: a new therapeutic strategy for cancer.
Banno K, Iida M, Yanokura M, Irie H, Masuda K, Kobayashi Y, Tominaga E, Aoki D. Banno K, et al. ScientificWorldJournal. 2015;2015:341362. doi: 10.1155/2015/341362. Epub 2015 Feb 3. ScientificWorldJournal. 2015. PMID: 25734181 Free PMC article. Review.
Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
Nunes M, Henriques Abreu M, Bartosch C, Ricardo S. Nunes M, et al. Int J Mol Sci. 2020 Oct 20;21(20):7768. doi: 10.3390/ijms21207768. Int J Mol Sci. 2020. PMID: 33092251 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information